SINOPHARM GROUP 1/5/O.N. (X2S1) — Financial Flexibility Index
SINOPHARM GROUP 1/5/O.N. (X2S1) has a Financial Flexibility Index of 0.06x as of December 2025. Free cash flow of €15.76 Billion (operating CF €14.14 Billion minus capex €1.62 Billion) represents 0% of total liabilities (€256.20 Billion). Also explore X2S1 net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SINOPHARM GROUP 1/5/O.N. Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for SINOPHARM GROUP 1/5/O.N. across 5 annual periods. Check SINOPHARM GROUP 1/5/O.N. (X2S1) asset resilience to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for SINOPHARM GROUP 1/5/O.N. (2021–2025)
Year-by-year free cash flow to debt coverage for SINOPHARM GROUP 1/5/O.N.. For the full company profile including market capitalisation, see SINOPHARM GROUP 1/5/O.N. (X2S1) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | €15.76 Billion | €14.14 Billion | €256.20 Billion | ▲ +21.1% |
| 2024 | 0.05x | €13.51 Billion | €11.55 Billion | €266.14 Billion | ▼ -31.5% |
| 2023 | 0.07x | €19.51 Billion | €17.17 Billion | €263.08 Billion | ▼ -19.2% |
| 2022 | 0.09x | €23.38 Billion | €20.96 Billion | €254.71 Billion | ▲ +87.2% |
| 2021 | 0.05x | €11.56 Billion | €9.31 Billion | €235.76 Billion | — |